3Bolli P,Burkart F,Vesanen K,et al.Electrocardiographic chan-ges during antihypertensive therapy in the international prospec-tive primary prevention study in hypertension[J].Hypertension,1987,9(6Pt 2):Ⅲ69-74.
4Wikstrand J.Primary prevention in patients with hypertension:comments on the clinical implications of the MAPHY Study.Metoprolol atherosclerosis prevention in hypertensives study[J].Am Heart J,1988,116(1Pt 2):338-347.
5Lampert R,Ickovics JR,Viscoli CJ,et al.Effects of propranolol on recovery of heart rate variability following acute myocardial in-farction and relation to outcome in the beta-blocker heart attack trial[J].Am J Cardiol,2003,91(2):137-142.
7Dorow P,Bethge H,Tnnesmann U.Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris[J].Eur J Clin Pharmacol,1986,31(2):143-147.
8Singh K,Communal C,Sawyer DB,et al.Adrenergic regulation of myocardial apotosis[J].Cardiovesc Res,2000,45(3):713-719.
9CIBIS-Ⅱinvestigators and committees.The cardiac insufficiency bisoprolol studyⅡ(CIBIS-Ⅱ):a randomized trial[J].Lancet,1999,353(9146):9-13.
1Ajay A, Waiters WP, Murclm MA. Can we learn to distinguish between “drug-like” and “non drug-like” molecules? [J ]. J Mad Owm, 1998,41:3314.
2Frimurer TM,Bywater R,Noenan L et al. Improving the odds in discriminating “drug-like” from“non drug-like” cxxntxamds[J].J Chem Inf Comput Sci,2000,40:1315.
3Lipinski CA,Lombardo F,Dominy BW,et al.Experimental and computational approaches to estimate solubility and permeability drug discovery[J]. Adv Drug Delivery Rev ,1997 , 23 : 3.
4Chan OH,Stewart BH.Physicochemical and drug-delivery considerations for oral drug biovailability[J]. Drug Discovery Today,1996,1:461.
5Fecik RA, Frank KE,Gentry EJ,et al. The search for orally active medications through combinatorial chemistry[ J ]. Med Res Rev, 1998,18:149.
6Navia MA, Chaturvedi PR. Design principles for orally bioavailable drugs[J]. Drug Discovery Today,1996,1:179.
7Kramer S D. Absorption prediction from physicochemical parameters[J]. Pharrn ,Sci Technol Today, 1999,2:373.
8Norinder U, Osterberg T, Artursson p. Theoretical calculation and predietion of Caco-2 cell prmeability using MolSurf parametrization and PLS statistics [J]. Pharm Res, 1997, 14:.1786.
9Winiwarter S,Bonham NM, Ax F, et al. Correlation of human jejunal permeability ( in vivo ) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach[J ]. J Med Chem, 1998,41 : 4939.
10Yalkowsky SH, Valvani SC. Solubility and partitioning I. Solubility of nonelectrolytes in water[J ]. J Pharm Sci, 1980,69: 912.
